You are here

  • Home
  • Archive
  • Volume 15, Issue Suppl 2
  • 000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY

Alerts

Article menu
Download PDFPDF
Poster Group 3A – Wednesday, September 28, 2005
000408 RANDOMIZED PHASE II STUDY OF DOCETAXEL VS EPIRU-BICIN/CYCLOPHOSPHAMID TO OPTIMIZE FIRST-LINE THERAPY OF METASTATIC BREAST CANCER: END RESULTS OF TIPP STUDY
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address